FDA Warns Over Says Billionaire's Claims About Anktiva
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
Compare the pros and cons of zero based budgeting and traditional budgeting, featuring practical considerations for different financial situations.
28,655 articlesFederal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
Berkshire Hathaway’s massive cash pile has long frustrated investors. Now the company is finally putting some of that...
As SpaceX eyes a potential mega-IPO, a veteran market strategist says the issue could force a broad rotation, unlocki...
As AI spending surges, a handful of ETFs offer broad, diversified access to the AI boom. Four funds map to the AI sta...
New York’s one-year moratorium on hyperscale data centers upends AI infrastructure planning and tests how governments...
The Supreme Court will hear a Boulder County climate-liability case against major oil producers, a move that could re...
Artemis II tightens the horizon for space infrastructure spending as major primes and component makers post strong ba...
ECL, EMN, and BCC report mixed quarters as 2026 guidance and cost actions set the tone for a volatile chemicals secto...
Rising political rhetoric around offshore wind threatens U.S. infrastructure spending, risking delays and higher cost...
A global push to deploy AI-ready data centers is boosting capital spending toward a roughly $1 trillion wave that cou...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...